POSTN and asthma: From a practical point of view, based on the present study, we propose a simple two-step algorithm for approaching biological therapy of severe asthma: step 1—classifying in T2 and non-T2 molecular phenotypes; step 2—endotyping as described, and within the same endotype, individual characterization and interpretation of available biomarkers and their dynamics, including periostin.